tiprankstipranks
Advertisement
Advertisement

ALMS Stock Latest News

Compelling Efficacy and Safety of Alumis’s Oral TYK2 Candidate Envu Underpins Buy Rating and $25 Target
RatingsCompelling Efficacy and Safety of Alumis’s Oral TYK2 Candidate Envu Underpins Buy Rating and $25 Target
20d ago
ALMS
Alumis falls -16.1%
PremiumThe Fly
Alumis falls -16.1%
1M ago
ALMS
Envu’s Compelling Efficacy and Superior Safety Profile Support Buy Rating on ALMS
PremiumRatings
Envu’s Compelling Efficacy and Superior Safety Profile Support Buy Rating on ALMS
1M ago
ALMS
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
PremiumThe Fly
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
1M ago
JNJ
TAK
Alumis price target raised to $55 from $50 at Oppenheimer
PremiumThe Fly
Alumis price target raised to $55 from $50 at Oppenheimer
1M ago
JNJ
TAK
Alumis Highlights Strong Phase 3 Psoriasis Results for Envudeucitinib
PremiumCompany AnnouncementsAlumis Highlights Strong Phase 3 Psoriasis Results for Envudeucitinib
1M ago
8K
ALMS
Alumis Inc. (ALMS): Buy Rating on Envu’s Strong Phase 3 Data and Attractive Risk‑Reward Ahead of 2026 FDA Submission
Premium
Ratings
Alumis Inc. (ALMS): Buy Rating on Envu’s Strong Phase 3 Data and Attractive Risk‑Reward Ahead of 2026 FDA Submission
1M ago
ALMS
Alumis price target lowered to $25 from $40 at H.C. Wainwright
Premium
The Fly
Alumis price target lowered to $25 from $40 at H.C. Wainwright
1M ago
ALMS
Alumis announces data from Phase 3 Onward1, Onward23 trials of envudeucitinib
PremiumThe Fly
Alumis announces data from Phase 3 Onward1, Onward23 trials of envudeucitinib
1M ago
ALMS
Alumis price target raised to $38 from $33 at Morgan Stanley
PremiumThe Fly
Alumis price target raised to $38 from $33 at Morgan Stanley
2M ago
ALMS
Alumis files automatic mixed securities shelf
PremiumThe Fly
Alumis files automatic mixed securities shelf
2M ago
ALMS
Alumis initiated with a Strong Buy at Raymond James
PremiumThe Fly
Alumis initiated with a Strong Buy at Raymond James
2M ago
ALMS
TYK2 Validation and Expanding Indications Drive Buy Rating and $40 Price Target for Alumis
PremiumRatingsTYK2 Validation and Expanding Indications Drive Buy Rating and $40 Price Target for Alumis
2M ago
ALMS
Alumis initiated with a Buy at Stifel
Premium
The Fly
Alumis initiated with a Buy at Stifel
2M ago
ALMS
Alumis rises 7.8%
Premium
The Fly
Alumis rises 7.8%
3M ago
ALMS
Alumis initiated with a Buy at Chardan
PremiumThe Fly
Alumis initiated with a Buy at Chardan
3M ago
ALMS
Alumis rises 10.2%
PremiumThe Fly
Alumis rises 10.2%
4M ago
ALMS
Alumis launches sizable common stock public offering
PremiumCompany Announcements
Alumis launches sizable common stock public offering
4M ago
8K
ALMS
Alumis price target raised to $40 from $20 at H.C. Wainwright
PremiumThe Fly
Alumis price target raised to $40 from $20 at H.C. Wainwright
4M ago
ALMS
Alumis 17.65M share Secondary priced at $17.00
PremiumThe FlyAlumis 17.65M share Secondary priced at $17.00
4M ago
ALMS
Alumis price target raised to $33 from $22 at Morgan Stanley
Premium
The Fly
Alumis price target raised to $33 from $22 at Morgan Stanley
4M ago
ALMS
Alumis price target raised to $32 from $18 at Guggenheim
Premium
The Fly
Alumis price target raised to $32 from $18 at Guggenheim
4M ago
TAK
ALMS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >